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SUMMARY
Background: Atopy is known to play an important role in the asthmatic disease.
The main objective of this study was to evaluate the frequency of sensitisation to
common aeroallergens in a cohort of asthmatics with different inflammatory pheno-
types and disease severity. Methods: We have conducted a retrospective cross-sec-
tional study including 772 asthmatics recruited between 2003 and 2014 in our
Asthma Clinic. The patients were defined as asthmatics on the basis of respiratory
symptoms together with a positive methacholine test (PC20M) < 16 mg/ml and/or a
reversibility to short-acting b2-agonists (salbutamol) ≥ 12% and 200 ml. Sensitisa-
tion to house dust mites, grass and birch pollens, cats, dogs and moulds was
assessed by RAST and a specific immunoglobulin E (IgE) > 0.35 kU/l was considered
as significant. Inflammatory phenotypes were subdivided between pauci-granulocytic
(n = 309) (40%), eosinophilic (n = 311) (40%), neutrophilic (N = 134) (17%) and
mixed-granulocytic (N = 18) (3%) asthmatics. Severe asthmatics (n = 118) were
defined according to the American Thoracic Society (ATS 2000) criteria and compared
with mild-to-moderate asthmatics (N = 654). Results: The eosinophilic phenotype
was associated with higher levels of total serum IgE compared with neutrophilic and
pauci-granulocytic asthma (p < 0.001 for both). Sensitisation rate to dogs and cats
was higher in eosinophilic asthmatics (31% and 37%, respectively, p < 0.01 both)
compared with neutrophilic (18% and 23% respectively) and pauci-granulocytic asth-
matics (20% and 24%, respectively), while sensitisation rate to house dust mites and
moulds were rather similar between the groups (ranging from 33% to 40% and from
10% to 16%, respectively). Severe asthmatics had slightly increased total serum IgE
compared with mild-to-moderate asthmatics (p < 0.05) without any difference in the
sensitisation rate to common aeroallergens. Conclusion: Eosinophilic asthma exhi-
bits higher total serum IgE and sensitisation rate towards animal dander while clinical
severity, though also associated with higher total IgE, did not preferentially relate to
any type of common aeroallergens.
What’s known
Immunoglobulin E (IgE)-mediated sensitisation to
aeroallergens is an established risk factor for asthma.
It is now recognised that asthma features different
airways inflammatory phenotypes.
What’s new
Here, we provide original data describing how IgE-
mediated sensitisation to aeroallergens relates to
inflammatory phenotypes in asthma.
Introduction
Atopy is defined as the propensity to raise specific
immunoglobulin E (IgE) to common aeroallergens
(1). Allergen-specific IgE binds to its cognate recep-
tors and is able to trigger a series of cellular events
like presentation of antigen by dendritic cells,
degranulation of mast cells and basophils leading to
the release of mediators playing an important role in
the disease symptoms (2). Prevalence in allergic dis-
eases is increasing worldwide and environmental fac-
tors such as exposure to allergens or air pollution
largely contribute to their development (3). A
European survey (ECRHS, 1994) estimates that the
prevalence of atopy reaches 34% in the general pop-
ulation with sensitisation to house dust mite (21%),
grass pollen (19%) and cats (8%) being the most fre-
quent (4). The population-based proportion of
asthma cases which are attributable to atopy was
found to range from one-third to one half according
to the country and the region (5).
Demographic factors like age, sex and tobacco sta-
tus have been shown to influence serum IgE levels
(6). According to ECRHS sensitisation to moulds
and, to a lesser extent to Dermatophagoides
pteronyssinus (Dpt), was a powerful risk factor for
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severe asthma in adults whereas it was not the case
for sensitisation to cats or pollen (7).
It is now accepted that asthma features different
airway inflammatory profiles, which has supported
the concept of inflammatory phenotype (8). The
relationship between serum IgE and sensitisation to
aeroallergens and airways inflammatory profile in
asthmatics has not been extensively studied (9).
There are epidemiological data showing that, in adult
asthmatics, sensitisation to moulds, furry animals
and food allergens (10) is associated with raised frac-
tion of exhaled nitric oxide (FeNO). Other studies
conducted in children showed a preferential associa-
tion between levels of FeNO and sensitisation
towards indoor, but not outdoor, aeroallergens (11).
In addition, level of domestic exposure to indoor
aeroallergens in sensitised patients was shown to fur-
ther enhance the FeNO levels (12). The purpose of
our study was to examine the relationship between
the level of serum total IgE and the sensitisation to
aeroallergens according to sputum cellular pheno-
types in a large asthma cohort seen at a university
hospital. In addition, we sought to determine if there
was any influence of age, sex and tobacco status as




We have conducted a retrospective study on 772
asthmatic patients recruited from the Asthma Clinic
(CHU of Liege, Sart-Tilman) between 2003 and
2014. Patients included in the study were those who
had successful sputum induction and serum IgE
measurements. Age of the patients ranged from 18
to 85 years. Among them, there were 654 mild-to-
moderate asthmatics and 118 severe asthmatics,
which were included in the Severe Belgian Asthma
Registry (13). A patient was considered as asthmatic
if he had chronic respiratory symptoms such as
wheeze, breathlessness or cough together with a
positive methacholine test (< 16 mg/ml) and/or a
FEV1 reversibility to short-acting b2-agonists
(salbutamol) ≥ 12% and 200 ml. Severe asthmatics
were defined according to the American Tho-
racic Society (ATS) criteria (14). In brief, patients
were uncontrolled despite usage of high doses of
inhaled corticosteroids (ICS) (fluticasone > 880 lg/
day) or oral corticosteroids as maintenance
treatment.
Serum total and specific immunoglobulin E (IgE)
were measured with the Radioallergosorbent test
(RAST) (Phadia, Groot-Bijgaarden, Belgium). The
positive threshold was > 0.35 kU/l. Atopy was
defined by at least one positive RAST (> 0.35 kU/l)
towards the following aeroallergens: house dust mite,
cat, dog, moulds, grass and birch pollen. The study
was approved by the Ethics Committee of CHU
Liege.
Sputum induction and processing
After premedication with 400 lg, inhaled salbutamol
administered by MDI (+Spacer), sputum was
Table 1 Patient demographic characteristics and disease severity according to sputum cellular phenotype
Eosinophilic
(N = 311) (40%)
Neutrophilic
(N = 134) (17%)
Pauci-granulocytic
(N = 309) (40%)
Mixed-granulocytic
(N = 18) (3%)
Age (years)
<40 (N = 262) 101 (38.5) 31 (12) 126 (48) 4 (1.5)
40–60 (N = 338) 141 (42) 65 (19)* 127 (38)*** 5 (1)
> 60 (N = 172) 69 (40) 38 (22)** 56 (33)** 9 (5)*
Sex
Male (N = 312) 148 (47) 42 (13) 115 (37) 7 (3)
Female (N = 460) 164 (36)† 92 (20)‡ 193 (42) 11 (2)
Tobacco status
Ex-smokers (N = 204) 88 (43) 37 (18) 73 (36) 6 (3)
Current smokers (N = 164) 66 (40) 24 (15) 73 (45.5) 1 (0.5)
Non-smokers (N = 398) 157 (39.5) 73 (18.5) 157 (39) 11 (3)
Severity of asthma
Mild-to-moderate (N = 654) 256 (39) 79 (12) 304 (46) 15 (3)
Severe (N = 118) 54 (46) 25 (21)§ 36 (30)¶ 3 (3)
Values within parentheses are expressed as percentages. *p < 0.05 vs. < 40 years, **p < 0.01 vs. < 40 years, ***p < 0.001 vs.
< 40 years; ‡p < 0.05 vs. male; §p < 0.05 vs. mild-to-moderate.
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Table 2 Comparison of serum total IgE and specific IgE to common aeroallergens according to the age of the patients
< 40 years (N = 262) 40–60 years (N = 338) > 60 years (N = 172)
Serum IgE (kU/l) 178 (2–17,183)**,‡ 102 (1–9235) 81 (1–5767)
≤ 113 94 (35%) 173 (53%) 100 (58%)
> 113 177 (65%)***,§ 155 (47%) 72 (42%)
House dust mite (kU/l) 1.58 (0–161)***,§ 0.49 (0–2029)§ 0.23 (0–61)
≤ 0.35 163 (60%) 198 (61%) 110 (64%)
> 0.35 107 (40%) 130 (39%) 62 (36%)
Cat (kU/l) 0.78 (0–111)***,§ 0.3 (0–111)‡ 0.17 (0–98)
≤ 0.35 145 (54%) 250 (76%) 151 (88%)
> 0.35 125 (46%)***,§ 78 (24%)‡ 21 (12%)
Dog (kU/l) 0.51 (0–111)***,§ 0.27 (0–111)§ 0.16 (0–28)
≤ 0.35 170 (63%) 254 (78%) 159 (92%)
> 0.35 100 (37%)***,§ 70 (22%)§ 13 (8%)
Moulds (kU/l) 0.23 (0–62)*,§ 0.18 (0–83) 0.16 (0–17)
≤ 0.35 223 (83%) 286 (88%) 151 (89%)
> 0.35 46 (17%) 39 (12%) 19 (11%)
Birch pollen (kU/l) 0.51 (0–199)**,§ 0.28 (0–111) 0.21 (0–111)
≤ 0.35 175 (65%) 270 (82%) 146 (86%)
> 0.35 93 (35%)***,§ 58 (18%) 24 (14%)
Grass pollen (kU/l) 1.23 (0–801)***,§ 0.32 (0–111)§ 0.18 (0–38)
≤ 0.35 123 (46%) 244 (74%) 147 (86%)
> 0.35 148 (54%)***,§ 84 (26%) 24 (14%)
*p < 0.05, **p < 0.01, ***p < 0.001 vs. 40–60 years. †p < 0.05, ‡p < 0.01, §p < 0.001 vs. > 60 years.
Table 3 Comparison of serum total IgE and specific IgE to common aeroallergens between males and females
Male (N = 312) Female (N = 460)
Serum IgE (kU/l) 155 (1–13,754)*** 98 (1–17,183)
≤ 113 124 (40%) 243 (53%)
> 113 188 (60%)*** 216 (47%)
House dust mite (kU/l) 0.87 (0–2029)** 0.49 (0–363)
≤ 0.35 196 (63%) 275 (60%)
> 0.35 116 (37%) 183 (40%)
Cat (kU/l) 0.36 (0–101) 0.38 (0–101)
≤ 0.35 219 (70%) 327 (71%)
> 0.35 92 (30%) 132 (29%)
Dog (kU/l) 0.29 (0–111) 0.3 (0–111)
≤ 0.35 234 (76%) 349 (76%)
> 0.35 75 (24%) 108 (24%)
Moulds (kU/l) 0.2 (0-83) 0.19 (0-46)
≤ 0.35 260 (85%) 400 (87%)
> 0.35 46 (15%) 58 (13%)
Birch pollen (kU/l) 0.39 (0–111)† 0.29 (0–199)
≤ 0.35 229 (74%) 362 (79%)
> 0.35 80 (26%) 95 (21%)
Grass pollen (kU/l) 0.57 (0–801)* 0.4 (0–469)
≤ 0.35 191 (61%) 323 (70%)
> 0.35 120 (39%)* 136 (30%)
*p < 0.05, **p < 0.01, ***p < 0.001 vs. Females. †p = 0.08.
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induced by inhalation of hypertonic saline (NaCl
5%) when FEV1 postsalbutamol was ≥ 65% pre-
dicted and isotonic saline (NaCl 0.9%) when FEV1
was < 65% predicted. Saline was combined with
additional salbutamol delivered by an ultrasonic neb-
uliser: Somerset, PA, USA with an output set at
0.9 ml/min as previously described (15). Each subject
inhaled the aerosol for three consecutive periods of
5 min and for a total time of 15 min.
The whole sputum was collected, weighted and
homogenised by adding three volumes of phosphate-
buffered saline (PBS), vortexed for 30 s and cen-
trifuged at 800 g for 10 min at 4 °C. Supernatant
was separated from cell pellet. We added DTT
(dithiotreitol) to the cells which were agitated for
20 min. Cells were washed once more with PBS and
resuspended in 1 ml. Squamous cells, total cell
counts and cell viability checked by trypan blue
exclusion were performed with a manual haemocy-
tometer as described previously (16). When squa-
mous cells were > 80%, the sample was considered
inappropriate (17). Ninety per cent of the samples
used for our study had squamous cell count ranging
from 0% to 50%. A patient was defined as eosino-
philic if he had a sputum eosinophil count ≥ 3%.
He was defined as neutrophilic if the sputum neu-
trophil count was ≥ 76%. Mixed-granulocytic
patients were defined by a sputum eosinophil count
≥ 3% and a sputum neutrophil count ≥ 76% and
pauci-granulocytic were those with a sputum eosino-
phil count < 3% and a sputum neutrophil count
< 76% (18).
Statistical analysis
Results were expressed as mean  SD or median
(range) according to the distribution of the data. For
the qualitative analysis, comparisons between groups
were performed using a chi-square test or a Fisher’s
exact t-test to compare the proportion between
groups. For quantitative analysis, we used a Kruskal–
Wallis test for a multiple group comparison followed
by a Dunn’s test and a Mann–Whitney test to com-
pare between two groups. A p < 0.05 was considered
as statistically significant.
Results
Patient demographic and functional
characteristics
Mild-to-moderate and severe asthmatics had similar
age (46  17 years for mild-to-moderate vs.
49  14 years for severe asthmatics). The female sex
was dominant both in mild-to-moderate asthmatics
(58%) and in severe asthmatics (69%), but the
Table 4 Comparison of serum total IgE and specific IgE to common aeroallergens according to the tobacco status
Ex-smokers (N = 204) Current smokers (N = 164) Non-smoker (N = 398)
Serum IgE (kU/l) 110 (2–17,183) 126 (1–8105) 120 (1–13,754)
≤ 113 102 (50%) 73 (45%) 188 (47%)
> 113 102 (50%) 90 (55%) 210 (53%)
House dust mite (kU/l) 0.4 (0–2029)** 0.51 (0–129)* 0.83 (0–363)
≤ 0.35 123 (61%) 108 (66%) 235 (59%)
> 0.35 80 (39%) 56 (34%) 162 (41%)
Cat (kU/l) 0.28 (0–111)** 0.35 (0–111) 0.43 (0–111)
≤ 0.35 158 (77%) 120 (73%) 263 (66%)
> 0.35 46 (23%)** 44 (27%) 133 (34%)
Dog (kU/l) 0.23 (0–111)** 0.28 (0–111) 0.34 (0–111)
≤ 0.35 170 (83%) 126 (77%) 282 (72%)
> 0.35 34 (17%)** 38 (23%) 110 (28%)
Moulds (kU/l) 0.19 (0–84) 0.17 (0–15) 0.2 (0–62)
≤ 0.35 178 (88%) 144 (89%) 332 (84%)
> 0.35 25 (12%) 18 (11%) 61 (16%)
Birch pollen (kU/l) 0.25 (0–111)** 0.24 (0–89)* 0.43 (0–199)
≤ 0.35 171 (85%) 135 (83%) 279 (71%)
> 0.35 31 (15%)*** 28 (17%)* 116 (29%)
Grass pollen (kU/l) 0.3 (0–111)*** 0.38 (0–74) 0.6 (0–801)
≤ 0.35 154 (75%) 114 (70%) 241 (61%)
> 0.35 50 (25%)*** 50 (30%)* 155 (39%)
*p < 0.05, **p < 0.01, ***p < 0.001 vs. non-smoker.
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proportion of female was higher in severe asthma
than in mild-to-moderate asthma (p < 0.05). The
number of never smokers was also lower in severe
than in mild-to-moderate asthma (41% vs. 54%)
(p < 0.001). The fraction of atopic patients was quite
similar between groups (61% in severe asthma vs.
55% in mild-to-moderate asthma). All severe asth-
matics were receiving high dose of inhaled corticoids
(ICS) (> 1000 lg equivalent fluticasone/day) and
long acting b2 agonists, while only 57% of mild-to-
moderate asthmatics were receiving ICS at an average
dosage of 268 lg fluticasone/day. Sixteen per cent of
severe asthmatics, but none of mild-to-moderate
asthmatics, were receiving maintenance treatment
with oral corticoids. None of the severe asthmatics
were receiving omalizumab at the time of the blood
and sputum sampling. FEV1 was clearly decreased in
severe asthmatics (65  21% predicted) compared
with mild-to-moderate asthmatics (86  19% pre-
dicted; p < 0.001). The distribution of patients
according to sputum cellular phenotype and age, sex,
tobacco status and disease severity are given in
Table 1. Males were more eosinophilic than females
(p < 0.01) while the neutrophilic phenotype was
more common in females (p < 0.05). The proportion
of neutrophilic asthma increased with the age and
the disease severity while the proportion of pauci-
granulocytic asthma showed changes going in the
opposite direction. In contrast, the proportion of
eosinophilic asthma was not influenced by age or
disease severity, but was the dominant phenotype in
severe asthmatics (see Table 1).
Serum total IgE/specific IgE according to
demographic and treatment features
There was a clear decrease in serum total IgE with
the age (p < 0.01). Sensitisation rate towards dogs,
cats, grass and birch pollen declined as age pro-
gressed while the rate of sensitisation towards house
dust mite and moulds remained stable across the dif-
ferent age groups (Table 2). Male had higher serum
total IgE and a higher rate of sensitisation to grass
pollen (39%) than female (30%) (p < 0.05; Table 3).
There was no difference in total serum IgE accord-
ing to the smoking status. Ex-smokers were charac-
terised by a reduced sensitisation rate to cats
(p < 0.01) dogs (p < 0.01), and grass and birch pol-
len (p < 0.001 for both) compared with never smok-
ers. Current smokers also showed reduced
sensitisation to grass and birch pollen (p < 0.05 for
both) compared with never smokers (Table 4). When
mild-to-moderate asthmatics were split according to
the use of ICS, serum total IgE was increased in
those taking ICS [75 kU/l (2–1783) vs. 119 kU/l
(0.1–9235), p < 0.001] together with the sensitisation
rate towards moulds compared to those without ICS
(18% vs. 11%, p < 0.05).
Serum total IgE/specific IgE according to
sputum cellular phenotypes
The distribution of the patients according to sputum
cellular phenotypes is 40% of eosinophilic, 17% of
neutrophilic, 40% of pauci-granulocytic and 3% of
mixed-granulocytic asthma. Serum total IgE was
higher in eosinophilic asthmatics [186 (0.1–17,183)]
when compared with neutrophilic [76 (2–8105)] and
pauci-granulocytic [91 (2–7338)] asthmatics (p
< 0.001 for both) (Figure 1A). Sensitisation rate to
dogs and cats were higher in eosinophilic asthmatics
(31% and 37%, respectively, p < 0.01 for both) com-
pared with neutrophilic (18% and 23% respectively)
and pauci-granulocytic asthmatics (20% and 24%
respectively) while sensitisation to house dust mites
and moulds were rather similar between the groups
(ranging from 33% to 40% and from 10% to 16%,
respectively). Sensitisation to grass and birch pollen
was higher in eosinophilic asthmatics (38% and 27%,
respectively, p < 0.05%) when compared with mixed-
granulocytic (11% and 6%, respectively) (Table 5)
(Figure 1B). We specifically analysed the patients
(A)
(B)
Figure 1 Comparison of serum total IgE (A) and
sensitisation to aeroallergens (B) according to sputum
cellular phenotypes. *p < 0.01 vs. neutrophilic and pauci-
granulocytic, #p < 0.05 vs. eosinophilic
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mono-sensitised to birch and/or grass pollen and com-
pared the sputum eosinophil counts between those
sampled during (N = 14) vs. outside (N = 26) the
critical season. There was no difference regarding spu-
tum eosinophils between asthmatics taken during or
outside the pollen season [0.5 (%) (0–24) vs. 1.2 (0–
93), respectively] neither regarding the dose of ICS
received by the patients at the time of sputum induc-
tion [400 lg/day (0–2000) vs. 400 lg/day (0–4200),
respectively] (Figure 2). Likewise, total serum IgE and
specific IgE towards pollens were not significantly dif-
ferent between the groups [Total IgE kU/l: 110 (7–
2824) vs. 70 (6–580), birch IgE kU/l: 1.2 (0–79) vs.
2.77 (0–69), grass IgE kU/l: 1.19 (0–243) vs. 4.32 (0.1–
25)].
Serum total IgE/specific IgE according to
clinical disease severity
Severe asthmatics displayed higher total serum IgE
compared to mild-to-moderate asthmatics
(p < 0.05) (Figure 3A and Table 6). However, sev-
ere asthmatics had not greater sensitisation rate to
any common aeroallergens compared to mild-to-
moderate asthma (Figure 3B). Specific IgE levels
towards birch pollen were even lower in severe asth-
matics compared to mild-to-moderate asthmatics
(p < 0.05, Table 6).










Serum IgE (kU/l) 186 (1–17,183)***,§ 76 (2–8105) 91 (2–7338) 96 (4–529)
≤ 113 106 (34%) 80 (60%) 172 (56%) 9 (50%)
> 113 205 (66%)*** 54 (40%) 136 (44%) 9 (50%)
House dust mite (kU/l) 1.23 (0–111)**,† 0.35 (0–363) 0.62 (0–2029) 0.38 (0–58)
≤ 0.35 189 (61%) 86 (65%) 184 (60%) 12 (67%)
> 0.35 121 (39%) 47 (35%) 125 (40%) 6 (33%)
Cat (kU/l) 0.53 (0–111)***,† 0.25 (0–111) 0.3 (0–111) 0.24 (0–11)
≤ 0.35 195 (63%) 103 (77%) 234 (76%) 14 (78%)
> 0.35 115 (37%)**,‡ 30 (23%) 75 (24%) 4 (22%)
Dog (kU/l) 0.42 (0–111)***,‡ 0.22 (0–111) 0.25 (0–101) 0.19 (0–3)
≤ 0.35 213 (69%) 107 (82%) 247 (80%) 16 (89%)
> 0.35 96 (31%)**,‡ 23 (18%) 62 (20%) 2 (11%)
Moulds (kU/l) 0.2 (0–83) 0.19 (0–40) 0.19 (0–62) 0.18 (0–5)
≤ 0.35 259 (84%) 112 (84%) 273 (90%) 16 (89%)
> 0.35 49 (16%) 21 (16%) 32 (10%) 2 (11%)
Birch pollen (kU/l) 0.39 (0–199)* 0.23 (0–69) 0.32 (0–111) 0.15 (0–6)
≤ 0.35 226 (73%) 108 (82%) 240 (78%) 17 (94%)
> 0.35 83 (27%)¶ 23 (18%) 68 (22%) 1 (6%)
Grass pollen (kU/l) 0.6 (0–801)** 0.32 (0–39) 0.44 (0–111) 0.16 (0–4)
≤ 0.35 192 (62%) 97 (72%) 209 (68%) 16 (89%)
> 0.35 118 (38%)¶ 37 (28%) 99 (32%) 2 (11%)
*p < 0.05, **p < 0.01, ***p < 0.001 vs. neutrophilic; †p < 0.05, ‡p < 0.01, §p < 0.001 vs. pauci-granulocytic; ¶p < 0.05,
††p < 0.01, ‡‡p < 0.001 vs. mixed-granulocytic.
Figure 2 Comparison of sputum eosinophils (%) between
asthmatics not exposed or exposed to pollens in patients
exclusively sensitised to grass/birch pollens. Season of
exposure for birch was from 1 March to 30 April and for
grass from 1 May to 30 June. Daily dose of inhaled ICS
and levels of specific IgE towards pollens were similar
between the two group
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Overall, there was no correlation between ACQ
and total serum IgE (r = 0.15; p = 0.15). There were
no differences in ACQ between patients not sensi-
tised (N = 352), sensitised to pollens only (N = 40),
to perennial allergens (N = 140) only or to perennial
allergens combined with pollens (240) (Figure 4).
It is worth noting that there was a clear increase
in sensitisation rate towards house dust mites, cats
and grass pollen in our asthmatic cohort compared
with a general population according to previously
published figures from a Belgium city involved in the
European Community Health Survey (4) (Table 6).
Some severe allergic asthmatics may benefit from a
treatment with omalizumab, a monoclonal antibody
directed towards IgE. In our series of severe asthmat-
ics, 28% met the three following criteria that would
place them as potential candidate for omalizumab:
total serum IgE ranging between 30 and 700 kU/l, at
least one sensitisation to a perennial allergen and
FEV1 (% predicted values) <80%.
Discussion
Here, we report for the first time an association
between the pattern of airway inflammation and the
IgE mediated sensitisation in a large cohort of
asthmatics. Our study shows that eosinophilic
asthmatics exhibit higher serum total IgE and sensiti-
sation rate towards cats and dogs. Severe asthmatics
were characterised by a slight increase in serum total
IgE when compared to mild-to-moderate asthmatics
without significant difference in the rate of sensitisa-
tion to common aeroallergens.
The relationship between total serum IgE and spu-
tum eosinophils confirms here, in a very large cohort
of well-characterised asthmatics, our previous finding
established on a limited series (16). Although signifi-
cant for the whole cohort, it is interesting to note
that this relationship is less convincing in older
patients in whom serum IgE levels decline, whereas
the proportion of eosinophilic asthma remains fairly
stable throughout the age classes. The particular asso-
ciation between cats and dogs and eosinophilic
asthma is an original finding. It is likely to reflect the
Th2 driven airway inflammatory process as the con-
sequence of continuous exposure to these perennial
allergens. Our finding is in keeping with a very recent
study conducted in a Korean population seeking
medical opinion for lower airway respiratory symp-
toms (19). In the latter study, positive skin prick tests
to cats and dogs were a risk factor for sputum
eosinophilia. In contrast to what we observed with
animal dander, and perhaps surprisingly, we did not
find such a relationship between the rate of house
dust mite and mould sensitisation and eosinophilic
inflammation although quantitative assessment of
specific IgE towards house dust mites show greater
values in eosinophilic asthmatics. Our finding is also
perfectly in line with the recent report of Patelis et al.
who showed that sensitisation to furry animals, but
not to mites, was a strong independent factor for ele-
vated FeNO, a biomarker of sputum eosinophils (10).
The reason for this is unclear. We could however
speculate that sensitised subjects are more prone to
take preventive measures to reduce humidity and
dust in their home than to separate from their pets.
We did not find raised sputum eosinophilia in
patients specifically and exclusively sensitised to pol-
lens and sampled during the season as opposed to
their counterparts sampled outside the season. Our
finding fits the lack of correlation between FeNO and
sensitisation to pollens observed in another cross-sec-
tional study (10). However, it does not exclude that
prolonged seasonal exposure to pollen in sensitised
asthmatics would have resulted in increased sputum
eosinophilia, but the retrospective and cross-sectional
design of our study is a clear limitation and does not
allow confirming this link.
Overall, neutrophilic phenotype shows total IgE
and an IgE sensitisation profile comparable to that
seen in pauci-granulocytic asthma. The sensitisation
(A)
(B)
Figure 3 Comparison of serum total IgE (A) and
sensitisation to aeroallergens (B) in mild-to-moderate vs.
severe asthmatics
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rate in non-eosinophilic phenotype was, however,
clearly higher than in a general population suggesting
that atopy is a risk factor for asthma whichever the
airway inflammatory phenotype. Likewise, total
serum IgE in neutrophilic and pauci-granulocytic
asthma, though often within the normal range, is at
least twice as high as the level reported in a general
population (21) and three times higher than in a
population excluding those with nasal allergic symp-
toms (22).
In our cross-sectional study, IgE was associated
with some demographic features including age, sex
and tobacco consumption. There was a clear decrease
in total serum IgE with advancing age which is in
line with longitudinal studies (23). Accordingly, there
was a reduction in the sensitisation rate for all types
of aeroallergens as age progresses except for house
dust mite, the sensitisation to which remained fairly
constant over the age categories. The reason for a
decrease in IgE with age is not known but could
reflect a facet of immune senescence. As aforemen-
tioned sputum eosinophilia, although linked to
serum IgE in the whole cohort, did not show reduc-
tion with age. This suggests that mechanisms favour-
ing eosinophilic airway inflammation may change
during the life and become less dependent on IgE
mediated pathway in the oldest patients. Our finding
of greater total serum IgE in male sex is confirma-
tory of a previous study at population level (24).
However, in contrast to Kerkhof et al., our data
Table 6 Comparison of serum total IgE and specific IgE to common aeroallergens between mild-to-moderate and
severe asthmatics
Reference population in Belgium





Serum IgE (kU/l) 110 (1–17,183) 162 (2–13,754)*
≤ 113 317 (49%) 50 (43%)
> 113 337 (51%) 67 (57%)
House dust mite (kU/l) 0.65 (0–2029) 0.47 (0–101)
≤ 0.35 402 (62%) 69 (60%)
> 0.35 22–27% 252 (38%) 47 (40%)
Cat (kU/l) 0.39 (0–111) 0.29 (0–101)
≤ 0.35 458 (70%) 88 (75%)
> 0.35 9% 195 (30%) 29 (25%)
Dog (kU/l) 0.3 (0–111) 0.29 (0–111)
≤ 0.35 497 (76%) 86 (75%)
> 0.35 155 (24%) 28 (25%)
Moulds (kU/l) 0.19 (0–83) 0.18 (0–31)
≤ 0.35 560 (87%) 100 (85%)
> 0.35 87 (13%) 17 (15%)
Birch pollen (kU/l) 0.35 (0–199) 0.25 (0–111)*
≤ 0.35 499 (77%) 92 (81%)
> 0.35 153 (23%) 22 (19%)
Grass pollen (kU/l) 0.45 (0.1–469) 0.39 (0.1–801)
≤ 0.35 437 (67%) 77 (65%)
> 0.35 16–17% 215 (33%) 41 (35%)
Results are expressed as median (minimum–maximum). *p < 0.05 vs. mild-to-moderate asthma. †p = 0.06 vs. mild-to-moderate
asthma.
Figure 4 ACQ comparison between asthmatics not
sensitised, sensitised to pollen only, sensitised to perennial
allergens only or sensitised to perennial allergens combined
with pollens. An ACQ above 1.5 denotes uncontrolled
asthma
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show equal sensitisation rate to house dust mites and
birch pollen in male and female asthmatics. In our
series, only the sensitisation rate to grass pollens was
found to be higher in males. Overall, the influence of
sexual hormone on IgE sensitisation remains unclear
and is certainly an area worth being further explored
(25).
We also found that ex-smokers were characterised
by a reduced sensitisation rate to cats, dogs, grass
and birch pollens when compared to non-smokers
while current smokers showed reduced sensitisation
to grass and birch pollens. More than 15 years ago,
Jarvis et al. showed in a population study, that cur-
rent smokers were at increased risk of sensitisation
to house dust mite but at decreased risk of sensitisa-
tion to grass and cats allergens (26). It is worth not-
ing that if smoking is associated with less frequent
sensitisation towards common aeroallergen, the total
serum IgE is very similar in smokers as compared
with never smokers. This may suggest that smoking
is triggering IgE production independently of sensiti-
sation to common aeroallergens.
We did not find association between asthma sever-
ity and any type of sensitisation. A previous cross-
sectional study from ECRHS has shown that sensiti-
sation to airborne moulds cladosporium and alter-
naria assessed by skin prick test was associated with
more severe asthma (7). Here, we could not confirm
this preferential association between severity and sen-
sitisation rate to moulds allergens but we did not
specifically select the type of moulds as RAST were
performed for a mixture including aspergillus,
alternaria, cladosporium and penicillium.
Furthermore, we determined sensitisation by measur-
ing serum specific IgE rather than assessing local
allergenic reaction, which may be considered as less
physiological than the skin prick tests. However, we
found that total serum IgE was greater in severe than
in mild-to-moderate asthmatics. Therefore, our data
suggest that it is the overall production of IgE rather
than the targeting of a specific aeroallergen that mat-
ters in determining asthma severity. To the best of
our knowledge, the link between the level of serum
IgE and asthma severity had not been described in a
large unselected asthma population so far. Support-
ing our observation, the role of IgE in severe asthma
has now been established by the demonstration of
the efficacy of omalizumab, a monoclonal antibody
directed to IgE, in treatment of severe atopic (27)
and non-atopic asthma (28). Omalizumab has
mainly been validated in those allergic patients sensi-
tised to a perennial aeroallergens with IgE ranging
from 30 to 700 kU/l. In our series of severe asthmat-
ics, only 28% satisfied the main criteria for consider-
ing treatment with omalizumab.
We conclude that eosinophilic asthma is associated
with raised serum IgE and, in particular, with a
greater sensitisation rate to domestic animal dander
while severe asthma display raised total serum IgE
without increase in sensitisation rate to any common
aeroallergen.
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